A Rare Incidence of Ethambutol Induced Toxic Optic Neuropathy
M. V. Mousigan, L. Nissi, V. Sreenivasan
International Journal of Medical and Pharmaceutical Case Reports · pp. 1–5 · Published 2 Jan 2023
10.9734/ijmpcr/2023/v16i1322Abstract
Ethambutol induces toxic optic neuropathy (EON), which most typically presents as bilateral symmetrical loss of vision and, due to a lack of early detection and adequate treatment, often causes serious irreversible visual impairment. EON is time and dose dependent. In this case report, we will discuss a 59-year-old female patient who came in with complaints of visual impairment, inclusive of a colour vision defect (dyschromatopsia) and blurred vision (scotoma). Her past medication history includes use of first-line anti-tubercular therapy (ATT) with four drugs: Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide. Pyrazinamide was taken for two months, and other medications (Rifampicin, Isoniazid, and Ethambutol) were taken for a period of seven months. From this case report, we will get a clear picture necessitating continuous monitoring for ocular toxicity.
Cited by 0
No indexed citations yet.
Related research
- Tachycardiomyopathy: Clinical Profile, Treatment and Outcome of a Series of Clinical Cases — shares topic coverage
- Atypical Post Partum Eclampsia and Posterior Reversible Encephalopathy Syndrome — shares topic coverage
- Recurrent Hematometra: A Rare Complication of Genital Tuberculosis — shares topic coverage
- Paradoxical Worsening of Extrapulmonary Tuberculosis in a Pediatric Case While on ATT: Diagnostic and Therapeutic Challenges — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.